Work

Genetic biomarkers predicting sensitivity to atezolizumab plus bevacizumab in resected hepatocellular carcinoma (HCC): A SNP prediction signature for HCC.

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e16014

Authors: Xiaopeng Tian, Wei-Juan Huang, Yangxun Pan, Minshan Chen, Dan Liao, Zhen-Zhong Zhou, Hailong Li, Song-Bin Guo, Wan-Ting Chen, Rong-Hui Chen

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Jinan University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province

OpenAlex ID: W7162688972

FWCI:

Cites:

Cited by:

Related to: